Recognizing and managing dermatologic manifestations of celiac disease in children

Celiac disease (CD) is a chronic autoimmune disorder triggered by gluten ingestion, affecting multiple organ systems beyond the gastrointestinal tract. Among its extraintestinal manifestations, dermatologic conditions play a significant role, particularly in pediatric patients. Dermatitis herpetiformis (DH), a hallmark dermatologic feature of CD, is characterized by intensely pruritic vesicles and papules predominantly on extensor surfaces. Other associated skin conditions include chronic eczema, psoriasis, alopecia areata and chronic urticaria, which, while less specific, are significantly more common in children with CD. The pathophysiology of these manifestations involves immune dysregulation, IgA immune complex deposition and heightened inflammatory responses, all linked to gluten sensitivity. Diagnosing CD in children with dermatologic symptoms poses challenges due to overlapping presentations with other skin disorders and variable serologic findings. Direct immunofluorescence of perilesional skin for IgA deposits remains the gold standard for DH, while serologic markers and intestinal biopsies support diagnosis in other cases. Non-specific manifestations often require a heightened clinical suspicion and a multidisciplinary diagnostic approach. Emerging non-invasive techniques may improve diagnostic accuracy and patient compliance in pediatric populations. Management centers on strict adherence to a gluten-free diet (GFD), which resolves most skin and systemic symptoms over time. Pharmacological interventions, such as dapsone, are crucial for symptomatic relief in DH while the GFD takes effect. Non-DH dermatologic conditions may necessitate adjunct therapies like immunosuppressants or biologics. Comprehensive management also addresses psychosocial impacts, with counseling and multidisciplinary care playing a pivotal role. Regular monitoring ensures adherence to treatment and evaluates outcomes, particularly in reducing symptom burden and improving quality of life. Understanding the dermatologic manifestations of CD in children enhances early recognition, timely intervention and holistic management, ultimately improving outcomes in this vulnerable population. Early detection through skin presentations highlights the need for integrating dermatologic findings into CD diagnostic frameworks.